Montai Therapeutics

Montai Therapeutics is a privately held biotechnology company focused on harnessing AI to decode diverse chemistry and develop breakthrough oral medicines for chronic diseases. The company has built the CONECTA™ platform with foundation models for decoding bioactive chemistry, and is advancing a pipeline of first-in-class oral medicines for inflammation and immunology.